Proceedings of the National Academy of Sciences · 1975 · 875 citations · 64 references
MedicinePharmacologyToxicologyFertilityReproductive BiologyReproductive ToxicologyMale InfertilityMale Reproductive ToxicologyReproductive PharmacologyReproductive ToxicityRodent ReproductionSperm FunctionMale Fertility ToxicityMale Reproductive Toxicity BiomarkersMitomycin C TreatmentSperm AbnormalitiesSperm Function AssessmentSperm Quality AbnormalitiesSpermatogenesis DisordersSpermatogenesis Disruption
The sperm of (C57BL X C3H)F1 mice were examined 1, 4, and 10 weeks after a subacute treatment with one of 25 chemicals at two or more dose levels. The fraction of sperm that were abnormal in shape was elevated above control values of 1.2-3.4% for methyl methanesulfonate, ethyl methanesulfonate, griseofulvin, benzo[a]pyrene, METEPA [tris(2-methyl-l-aziridinyl)phosphine oxide], THIO-TEPA [tris(l-aziridinyl)phosphine sulfide], mitomycin C, myleran, vinblastine sulphate, hydroxyurea, 3-methylcholanthrene, colchicine, actinomycin D, imuran, cyclophosphamide, 5-iododeoxyuridine, dichlorvos, aminopterin, and trimethylphosphate. Dimethylnitrosamine, urethane, DDT [1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane], 1,1-dimethylhydrazine, caffeine, and calcium cyclamate did not induce elevated levels of sperm abnormalities. The results suggest that sperm abnormalities might provide a rapid inexpensive mammalian screen for agents that lead to errors in the differentiation of spermatogenic stem cells in vivo and thus indicate agents which might prove to be mutagenic, teratogenic, or carcinogenic.
64
Detection of chemical mutagens by the dominant lethal assay in the mouse
Samuel S. Epstein, Elsie Arnold, J. Andrea et al. · Toxicology and Applied Pharmacology · 1972 · 565 citations
Pharmacy, Genetics, Toxicology +12
Peter Swann, Peter Magee · Biochemical Journal · 1968 · 373 citations · Full text
Medicine, Pharmacology, Toxicology +12
Teratology-principles and techniques
L. Oberthur Johnson · Metabolism · 1965 · 261 citations